Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03032523 · ClinicalTrials.gov registry record · NA
Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM)
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03032523: Completed NA study, sponsored by Stanford University.
NCT03032523 is a NA study that has completed, run by Stanford University. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03032523, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Hypoglycemia is the most common metabolic problem faced after birth. The investigators will be studying the utility of using a continuous glucose monitoring(CGM) system to more closely monitor low blood sugars in newborns. The investigators will evaluate the number of hypoglycemic events detected using CGM and compare it to those detected using current standard of care screening methods.
Interventions
- DIAGNOSTIC_TEST Standard of care glucose test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2018-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03032523
The ClinicalTrials.gov registry entry for NCT03032523 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standard of care glucose test is the first listed.
NCT03032523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03032523 about?
NCT03032523 is a clinical study titled "Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM)". Hypoglycemia is the most common metabolic problem faced after birth. The investigators will be studying the utility of using a continuous glucose monitoring(CGM) system to more closely monitor low blood sugars in newborns. The investigators will evaluate the number of hypoglycemic events detected us...
What is the current status of trial NCT03032523?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2016-10-01. Estimated completion is 2018-04-01.
What interventions are being tested in trial NCT03032523?
The interventions under investigation include: Standard of care glucose test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03032523?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.